Initial Workup for an Adult with Chronic Kidney Disease (CKD)
The initial workup for an adult with CKD should include measurement of both estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR), as these are essential for diagnosis, staging, and risk stratification. 1
Diagnostic Confirmation
Confirm CKD diagnosis:
Essential laboratory tests:
- Serum creatinine with eGFR calculation
- Urine albumin-to-creatinine ratio (UACR)
- Complete blood count (CBC) with differential
- Comprehensive metabolic panel
- Urinalysis with microscopic examination 2
Risk Stratification
CKD staging and risk classification:
Cardiovascular risk assessment:
Evaluation of Etiology
Determine potential causes:
- Review medical history for diabetes, hypertension, cardiovascular disease
- Family history of kidney disease
- Medication review (NSAIDs, nephrotoxic drugs)
- Social and environmental exposures 1
Additional testing based on clinical suspicion:
Consider kidney biopsy:
- When cause remains unclear after initial workup
- Rapid decline in kidney function
- Significant proteinuria
- Active urinary sediment 1
Management Planning
Blood pressure management:
Medication review and adjustment:
- Evaluate current medications for potential nephrotoxicity
- Adjust medication dosages as needed based on eGFR
- Consider SGLT2 inhibitors for appropriate patients 1
Metabolic complications screening:
- Electrolytes (potassium, sodium)
- Acid-base status
- Calcium and phosphate
- Vitamin D levels
- Parathyroid hormone 3
Common Pitfalls to Avoid
Relying solely on serum creatinine:
Neglecting albuminuria assessment:
Assuming all renal dysfunction is CKD:
- Rule out acute kidney injury
- Consider non-renal causes of elevated BUN 2
Delaying nephrology referral:
- Refer promptly if:
- eGFR <30 mL/min/1.73 m²
- Albuminuria ≥300 mg/g
- Rapid decline in eGFR
- Unclear etiology requiring biopsy 3
- Refer promptly if:
By following this systematic approach to the initial workup of CKD, clinicians can accurately diagnose, stage, and develop appropriate management plans to reduce morbidity and mortality associated with kidney disease progression and its complications.